news

 

Magic Circle law firm Clifford Chance and Allens have advised Netherlands-based consumer finance provider Home Credit Group on the 800-million-euro ($870 million) sale of its Vietnam business to Thailand’s Siam Commercial Bank, which was advised by Linklaters and Vilaf.

Home Credit Vietnam is Vietnam’s second-largest consumer finance company by market share, with more than 15 million customers.

The sale of the Vietnam business marks the latest Southeast divestment by Home Credit, which in 2022 offloaded its Philippines and Indonesian businesses to Japanese banking giant MUFG for $621 million. Clifford Chance advised Home Credit on that deal as well, while Nishimura & Asahi advised MUFG.

The Clifford Chance team was led by Hong Kong partner Emma Davies, with support from partners Zayed Al Jamil (tech and data separation) and Nicola Hemsley (international tax aspects).

The Linklaters team was led by partner Sutthipong Koohasaneh, with support from Matthew Middleditch, chairman of the global corporate practice.

The Vilaf team was led by chairperson Duyen Ha Vo and included partners Phong Tran, Tung Nguyen, and Lam Nguyen.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Top CAM dealmaker rocks market with move to Khaitan

by Nimitt Dixit |

Top Indian dealmaker Shishir Vayttaden has left the equity partnership at Cyril Amarchand Mangaldas to join Khaitan & Co, along with two other partners in his team, K. Aishwarya and Aditi Singhvi.

White & Case guides $380mln U.S.-Japan LNG deal

by Nimitt Dixit |

Global law firm White & Case has advised Japan Petroleum Exploration Co. (JAPEX) on the acquisition through its U.S. subsidiary of an equity interest in Gulf Coast LNG Holdings, which owns an interest in the Freeport LNG project in Texas, from JERA Americas for approximately $380 million.

Reed Smith, Freshfields, Kirkland on Henlius’ $691 mln take-private deal

Freshfields Bruckhaus Deringer is representing Hong Kong-listed biotech company Henlius on its $691 million take-private deal offer from Shanghai Fosun New Medicine Research Company, which is being advised by Reed Smith.